Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Félicie Costantino, MD, PhD

AP-HP
Boulogne-Billancourt, France

Professor of Rheumatology

Presentation(s):

  • 0103: Common and Rare Variant Contributions to Familial Aggregation in Spondyloarthritis

    Sunday, October 26, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Terminated); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Celltrion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Janssen: Advisor or Review Panel Member (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); UCB: Advisor or Review Panel Member (Terminated)

  • 0104: Dissecting the Genetic and Functional Association of CARD9 with Axial Spondyloarthritis

    Sunday, October 26, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Terminated); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Celltrion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Janssen: Advisor or Review Panel Member (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); UCB: Advisor or Review Panel Member (Terminated)

  • 1438: Similar Efficacy of Bimekizumab in Two Clinical Endotypes of Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies and Their Open-Label Extension

    Monday, October 27, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Terminated); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Celltrion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Janssen: Advisor or Review Panel Member (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); UCB: Advisor or Review Panel Member (Terminated)